These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12271597)

  • 21. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].
    Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379
    [No Abstract]   [Full Text] [Related]  

  • 22. A systematic review of tegaserod for the treatment of irritable bowel syndrome.
    Bergmann K
    J Clin Pharm Ther; 2003 Apr; 28(2):151-3; author reply 153. PubMed ID: 12713613
    [No Abstract]   [Full Text] [Related]  

  • 23. Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?
    Shen B; Soffer EE
    Cleve Clin J Med; 2003 Jan; 70(1):64-5. PubMed ID: 12549728
    [No Abstract]   [Full Text] [Related]  

  • 24. Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.
    Whorwell PJ
    Gut; 2001 May; 48(5):596-7. PubMed ID: 11302953
    [No Abstract]   [Full Text] [Related]  

  • 25. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 26. [Contemporary approaches to the treatment of the irritable bowel syndrome in pilots].
    Preobrazhenskiĭ VN; Vasilenko VV
    Aviakosm Ekolog Med; 1999; 33(4):60-2. PubMed ID: 10530389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
    Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zelnorm: new treatment available for women with IBS.
    Nursing; 2002 Oct; 32(10):24, 26. PubMed ID: 12400584
    [No Abstract]   [Full Text] [Related]  

  • 30. [Functional colonic diseases: from physiopathology to pharmacology].
    Bardou M
    Rev Med Interne; 1999 Feb; 20(2):151-7. PubMed ID: 10227093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating irritable bowel syndrome.
    Bickston SJ
    Health News; 1999 Jan; 5(1):3. PubMed ID: 9932538
    [No Abstract]   [Full Text] [Related]  

  • 32. Irritable bowel syndrome: new tools and insights for the primary care physician.
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S8-20. PubMed ID: 12825863
    [No Abstract]   [Full Text] [Related]  

  • 33. [Irritable bowel syndrome(IBS)].
    Kawasaki Y; Fujita K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):559-62. PubMed ID: 12877049
    [No Abstract]   [Full Text] [Related]  

  • 34. [Symptomatic therapy of irritable bowel syndrome. Which drug for which symptoms?].
    Madisch A; Hotz J
    MMW Fortschr Med; 2001 Sep; 143(39):28-30. PubMed ID: 11680924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized herbal treatments on functional bowel disorders: moving from putative mechanisms of action to controlled clinical trials.
    Cremonini F
    Neurogastroenterol Motil; 2014 Jul; 26(7):893-900. PubMed ID: 24965903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Irritable colon].
    Lindberg M
    Ugeskr Laeger; 2001 Oct; 163(41):5694. PubMed ID: 11665483
    [No Abstract]   [Full Text] [Related]  

  • 37. Innovative treatments for irritable bowel syndrome featured in new continuing ed program.
    Rep Med Guidel Outcomes Res; 2000 Jul; 11(14):1-2, 5-6. PubMed ID: 11771560
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug treatment for irritable bowel syndrome].
    Hillilä M; Färkkilä M
    Duodecim; 2004; 120(20):2453-8. PubMed ID: 15641514
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
    Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complex therapy of patients with the irritable bowel syndrome].
    Osipenko MF; Bikbulatova EA; Frolova NN; Loseva NV
    Eksp Klin Gastroenterol; 2004; (5):39-44. PubMed ID: 15770859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.